US equities
|
TSLA
$395.04
▲+6.13%
MU
$894.34
▲+1.91%
SPCX
$148.58
▲+0.74%
NVDA
$216.46
▲+2.60%
META
$646.80
▲+0.65%
SNDK
$1,248.00
▲+0.81%
AAPL
$346.37
▼-0.39%
AMZN
$250.35
▲+0.95%
TSLA
$395.04
▲+6.13%
MU
$894.34
▲+1.91%
SPCX
$148.58
▲+0.74%
NVDA
$216.46
▲+2.60%
META
$646.80
▲+0.65%
SNDK
$1,248.00
▲+0.81%
AAPL
$346.37
▼-0.39%
AMZN
$250.35
▲+0.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
InMed Pharmaceuticals Inc. - Common Shares
(NQ:
INM
)
1.450
+0.010 (+0.69%)
Delayed Quote
Updated: 10:41 AM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about InMed Pharmaceuticals Inc. - Common Shares
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
24 Stocks Moving in Thursday's Pre-Market Session
↗
November 18, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) rose 33% to $50.80 in pre-market trading. Sono Group shares climbed 155% on Wednesday after the company priced its IPO at $15 per share....
Via
Benzinga
Topics
Initial Public Offering
InMed Pharmaceuticals Working to Address Rare Cannabinoid Opportunities
↗
November 17, 2021
InMed Pharmaceuticals (NASDAQ:
Via
Benzinga
InMed Pharmaceuticals (INM): Progress Across the Business
November 17, 2021
LONDON, UK / ACCESSWIRE / November 17, 2021 / With the recent closing of the BayMedica acquisition, InMed now has a substantially different profile than just a few months ago. The company is now in its...
From
Edison Investment Research Limited
Via
AccessWire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Working on Answer to Mass Production of Rare, Otherwise Depleted Cannabinoid Opportunities
November 16, 2021
Via
Investor Brand Network
Topics
Cannabis
InMed Pharmaceuticals Files Patent Application for Treatment of Neurodegenerative Diseases with Rare Cannabinoid
↗
November 11, 2021
InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabi...
Via
Benzinga
Topics
Intellectual Property
InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid
November 10, 2021
Via
Investor Brand Network
Topics
Intellectual Property
InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid
November 10, 2021
Via
CannabisNewsWire
Topics
Intellectual Property
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Results, Business Updates for Q1 2022
November 10, 2021
Via
Investor Brand Network
Topics
Intellectual Property
InMed Pharmaceuticals Inc. Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid
↗
November 03, 2021
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development, and commercialization of rare cannabinoids, today announced its filing of an international patent...
Via
Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid
November 03, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities
↗
November 02, 2021
Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly-listed Ginkgo Bioworks Holdings Inc., in what is the largest-...
Via
Benzinga
Topics
Initial Public Offering
Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production
November 01, 2021
Via
Investor Brand Network
Topics
Initial Public Offering
Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production
November 01, 2021
Via
CannabisNewsWire
Topics
Initial Public Offering
55 Biggest Movers From Friday
↗
October 25, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...
Via
Benzinga
35 Stocks Moving In Friday's Mid-Day Session
↗
October 22, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) rose 1099% to $18.35. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated...
Via
Benzinga
26 Stocks Moving in Friday's Pre-Market Session
↗
October 22, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) rose 300% to $6.10 in pre-market trading. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition...
Via
Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
↗
October 21, 2021
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 34.9% to $13.44 in pre-market trading after announcement of a proposed merger with Trump Media & Technology Group...
Via
Benzinga
Topics
Government
46 Biggest Movers From Yesterday
↗
October 19, 2021
Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
↗
October 18, 2021
Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare....
Via
Benzinga
21 Stocks Moving in Monday's Pre-Market Session
↗
October 18, 2021
Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine...
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Completion of BayMedica Acquisition
October 14, 2021
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Completion of BayMedica Acquisition
October 14, 2021
Via
CannabisNewsWire
18 Stocks Moving in Thursday's Pre-Market Session
↗
October 14, 2021
Gainers TSR, Inc. (NASDAQ: TSRI) rose 40.2% to $12.89 in pre-market trading after the company reported record revenue for its first quarter. Cemtrex, Inc. (NASDAQ: CETX) rose 34....
Via
Benzinga
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Poised to Become Global Leader in Manufacture of Rare Cannabinoids
October 08, 2021
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment
September 30, 2021
Via
CannabisNewsWire
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
↗
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
↗
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
↗
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
↗
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment
September 30, 2021
Via
Investor Brand Network
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
